Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
612 | 14056 | 29.7 | 61% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
21 | 4 | UROLOGY & NEPHROLOGY//UROL//JOURNAL OF UROLOGY | 229838 |
612 | 3 | ANABOLIC STEROIDS//CLENBUTEROL//ANABOLIC ANDROGENIC STEROIDS | 14056 |
1973 | 2 | ANABOLIC STEROIDS//DOPING CONTROL//DOPING ANALYSIS | 5624 |
2266 | 2 | ANABOLIC ANDROGENIC STEROIDS//KHAT//ANABOLIC STEROIDS | 4657 |
3019 | 2 | CLENBUTEROL//RACTOPAMINE//BETA AGONISTS | 2525 |
3609 | 2 | COUNTERFEIT MEDICINES//ONLINE PHARMACIES//SILDENAFIL ANALOGUE | 1250 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANABOLIC STEROIDS | authKW | 632549 | 3% | 66% | 441 |
2 | CLENBUTEROL | authKW | 552504 | 3% | 67% | 380 |
3 | ANABOLIC ANDROGENIC STEROIDS | authKW | 449292 | 2% | 79% | 261 |
4 | RACTOPAMINE | authKW | 390691 | 2% | 85% | 213 |
5 | KHAT | authKW | 266819 | 1% | 85% | 145 |
6 | BETA AGONISTS | authKW | 200454 | 2% | 40% | 233 |
7 | DOPING CONTROL | authKW | 158372 | 1% | 51% | 143 |
8 | NANDROLONE | authKW | 145707 | 1% | 69% | 98 |
9 | DIETARY SUPPLEMENTS | authKW | 145667 | 3% | 19% | 361 |
10 | CATHA EDULIS | authKW | 123051 | 0% | 90% | 63 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Analytical | 51404 | 27% | 1% | 3738 |
2 | Biochemical Research Methods | 15253 | 12% | 1% | 1649 |
3 | Pharmacology & Pharmacy | 12072 | 19% | 0% | 2680 |
4 | Sport Sciences | 7194 | 6% | 0% | 806 |
5 | Nutrition & Dietetics | 3266 | 5% | 0% | 650 |
6 | Food Science & Technology | 2721 | 6% | 0% | 866 |
7 | Medical Laboratory Technology | 2665 | 3% | 0% | 356 |
8 | Substance Abuse | 2507 | 2% | 0% | 306 |
9 | Toxicology | 2419 | 5% | 0% | 659 |
10 | Endocrinology & Metabolism | 2312 | 6% | 0% | 867 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTIDOPING | 79024 | 1% | 45% | 81 |
2 | DOPING CONTROL | 62180 | 1% | 30% | 96 |
3 | PREVENT DOPING | 53022 | 1% | 30% | 81 |
4 | DOCO | 47267 | 0% | 68% | 32 |
5 | BIOANAL GRP | 36878 | 0% | 38% | 45 |
6 | SWISS DOPING ANAL | 34263 | 0% | 44% | 36 |
7 | ERCA | 34246 | 0% | 37% | 43 |
8 | DOPING CONTROL ATHENS | 33650 | 0% | 52% | 30 |
9 | RACING | 31904 | 0% | 45% | 33 |
10 | ADV ANAL TEAM | 29998 | 0% | 63% | 22 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG TESTING AND ANALYSIS | 67891 | 1% | 18% | 171 |
2 | STEROIDS | 22375 | 2% | 5% | 213 |
3 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 19836 | 2% | 3% | 320 |
4 | JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 18854 | 2% | 3% | 327 |
5 | JOURNAL OF ANIMAL SCIENCE | 11668 | 2% | 2% | 301 |
6 | FARMACIA | 10824 | 0% | 8% | 67 |
7 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 10179 | 1% | 2% | 209 |
8 | FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT | 9221 | 1% | 4% | 118 |
9 | JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 7813 | 1% | 3% | 115 |
10 | BIOMEDICAL CHROMATOGRAPHY | 6750 | 1% | 3% | 106 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANABOLIC STEROIDS | 632549 | 3% | 66% | 441 | Search ANABOLIC+STEROIDS | Search ANABOLIC+STEROIDS |
2 | CLENBUTEROL | 552504 | 3% | 67% | 380 | Search CLENBUTEROL | Search CLENBUTEROL |
3 | ANABOLIC ANDROGENIC STEROIDS | 449292 | 2% | 79% | 261 | Search ANABOLIC+ANDROGENIC+STEROIDS | Search ANABOLIC+ANDROGENIC+STEROIDS |
4 | RACTOPAMINE | 390691 | 2% | 85% | 213 | Search RACTOPAMINE | Search RACTOPAMINE |
5 | KHAT | 266819 | 1% | 85% | 145 | Search KHAT | Search KHAT |
6 | BETA AGONISTS | 200454 | 2% | 40% | 233 | Search BETA+AGONISTS | Search BETA+AGONISTS |
7 | DOPING CONTROL | 158372 | 1% | 51% | 143 | Search DOPING+CONTROL | Search DOPING+CONTROL |
8 | NANDROLONE | 145707 | 1% | 69% | 98 | Search NANDROLONE | Search NANDROLONE |
9 | DIETARY SUPPLEMENTS | 145667 | 3% | 19% | 361 | Search DIETARY+SUPPLEMENTS | Search DIETARY+SUPPLEMENTS |
10 | CATHA EDULIS | 123051 | 0% | 90% | 63 | Search CATHA+EDULIS | Search CATHA+EDULIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | POPE, HG , WOOD, RI , ROGOL, A , NYBERG, F , BOWERS, L , BHASIN, S , (2014) ADVERSE HEALTH CONSEQUENCES OF PERFORMANCE-ENHANCING DRUGS: AN ENDOCRINE SOCIETY SCIENTIFIC STATEMENT.ENDOCRINE REVIEWS. VOL. 35. ISSUE 3. P. 341-375 | 202 | 65% | 28 |
2 | HARTGENS, F , KUIPERS, H , (2004) EFFECTS OF ANDROGENIC-ANABOLIC STEROIDS IN ATHLETES.SPORTS MEDICINE. VOL. 34. ISSUE 8. P. 513 -554 | 150 | 79% | 303 |
3 | SAGOE, D , MOLDE, H , ANDREASSEN, CS , TORSHEIM, T , PALLESEN, S , (2014) THE GLOBAL EPIDEMIOLOGY OF ANABOLIC-ANDROGENIC STEROID USE: A META-ANALYSIS AND META-REGRESSION ANALYSIS.ANNALS OF EPIDEMIOLOGY. VOL. 24. ISSUE 5. P. 383-398 | 106 | 85% | 33 |
4 | FEYISSA, AM , KELLY, JP , (2008) A REVIEW OF THE NEUROPHARMACOLOGICAL PROPERTIES OF KHAT.PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. VOL. 32. ISSUE 5. P. 1147 -1166 | 123 | 86% | 73 |
5 | KANAYAMA, G , HUDSON, JI , POPE, HG , (2008) LONG-TERM PSYCHIATRIC AND MEDICAL CONSEQUENCES OF ANABOLIC-ANDROGENIC STEROID USE: A LOOMING PUBLIC HEALTH CONCERN?.DRUG AND ALCOHOL DEPENDENCE. VOL. 98. ISSUE 1-2. P. 1 -12 | 113 | 88% | 87 |
6 | KANAYAMA, G , HUDSON, JI , POPE, HG , (2010) ILLICIT ANABOLIC-ANDROGENIC STEROID USE.HORMONES AND BEHAVIOR. VOL. 58. ISSUE 1. P. 111 -121 | 125 | 74% | 63 |
7 | BARCELOUX, DG , PALMER, RB , (2013) ANABOLIC ANDROGENIC STEROIDS.DM DISEASE-A-MONTH. VOL. 59. ISSUE 6. P. 226 -248 | 111 | 88% | 3 |
8 | ROCHA, T , AMARAL, JS , OLIVEIRA, MBPP , (2016) ADULTERATION OF DIETARY SUPPLEMENTS BY THE ILLEGAL ADDITION OF SYNTHETIC DRUGS: A REVIEW.COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY. VOL. 15. ISSUE 1. P. 43 -62 | 93 | 83% | 1 |
9 | MHILLAJ, E , MORGESE, MG , TUCCI, P , BOVE, M , SCHIAVONE, S , TRABACE, L , (2015) EFFECTS OF ANABOLIC-ANDROGENS ON BRAIN REWARD FUNCTION.FRONTIERS IN NEUROSCIENCE. VOL. 9. ISSUE . P. - | 110 | 74% | 2 |
10 | MANGHI, RA , BROERS, B , KHAN, R , BENGUETTAT, D , KHAZAAL, Y , ZULLINO, DF , (2009) KHAT USE: LIFESTYLE OR ADDICTION?.JOURNAL OF PSYCHOACTIVE DRUGS. VOL. 41. ISSUE 1. P. 1-10 | 98 | 88% | 16 |
Classes with closest relation at Level 3 |